CytomX Therapeutics (CTMX) Non-cash Items (2014 - 2025)

CytomX Therapeutics has reported Non-cash Items for 12 years, with the latest figure at $24.6 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 132.77% year-over-year to $24.6 million; the trailing twelve-month figure through Dec 2025 stood at $24.6 million (up 132.77% YoY), and the FY2025 full-year result was $24.6 million, up 132.77% from the prior year.
• Non-cash Items for Q4 2025 stood at $24.6 million, up from $10.6 million in the prior quarter.
• The five-year high for Non-cash Items was $24.6 million in Q4 2025, with the low at $5.3 million in Q1 2021.
• Historically, Non-cash Items has averaged $9.2 million across 5 years, with a median of $6.7 million in 2021.
• Annual changes were most pronounced in 2021 — Non-cash Items slumped 73.9% — and 2025, when it soared 132.77%.
• CytomX Therapeutics' Non-cash Items stood at $6.1 million in 2021, then grew by 22.7% to $7.4 million in 2022, then grew by 10.37% to $8.2 million in 2023, then rose by 28.85% to $10.6 million in 2024, then surged by 132.77% to $24.6 million in 2025.
• The last three Non-cash Items figures came in at $24.6 million (Q4 2025), $10.6 million (Q4 2024), and $8.2 million (Q4 2023), per Business Quant data.